These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24239300)

  • 21. Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation.
    Koskinas KC; Fragakis N; Katritsis D; Skeberis V; Vassilikos V
    Europace; 2014 Jul; 16(7):973-9. PubMed ID: 24473502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of antiarrhythmic therapy with intravenous loading dose of amiodarone: evidence for an altered response in diabetic patients.
    Iervasi G; Clerico A; Bonini R; Nannipieri M; Manfredi C; Sabatino L; Biagini A; Donato L
    Int J Clin Pharmacol Res; 1998; 18(3):109-20. PubMed ID: 9825267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaphylaxis during intravenous administration of amiodarone.
    Okuyan H; Altin C; Arihan O
    Ann Card Anaesth; 2013; 16(3):229-30. PubMed ID: 23816686
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis.
    De Vecchis R; Ariano C; Giasi A; Cioppa C
    Minerva Cardioangiol; 2018 Jun; 66(3):349-359. PubMed ID: 28497941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term onset of fatal pulmonary toxicity in a patient treated with intravenous amiodarone for post-operative atrial fibrillation.
    Boriani G; Ferruzzi L; Corti B; Ruffato A; Gavelli G; Mattioli S
    Int J Cardiol; 2012 Aug; 159(1):e1-4. PubMed ID: 22130226
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute amiodarone syndrome after a single intravenous amiodarone bolus.
    Ng XR; Wee LY; Chadachan V
    Singapore Med J; 2012 Nov; 53(11):e225-7. PubMed ID: 23192509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
    Kafkas NV; Patsilinakos SP; Mertzanos GA; Papageorgiou KI; Chaveles JI; Dagadaki OK; Kelesidis KM
    Int J Cardiol; 2007 Jun; 118(3):321-5. PubMed ID: 17049640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute fatal post-CABG low dose amiodarone lung toxicity.
    Argyriou M; Hountis P; Antonopoulos N; Mathioudaki M
    Asian Cardiovasc Thorac Ann; 2007 Dec; 15(6):e66-8. PubMed ID: 18042762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and therapeutic aspects of amiodarone induced thyroid dysfunction.
    Costache II; Aprotosoaie AC
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):375-9. PubMed ID: 24340519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral amiodarone-related phlebitis: an institutional nursing guideline to reduce patient harm.
    Spiering M
    J Infus Nurs; 2014; 37(6):453-60. PubMed ID: 25376322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow granulomas possibly associated with amiodarone.
    Yamreudeewong W; McIntyre WW; Sun TJ; Ranelli PL
    Pharmacotherapy; 2000 Jul; 20(7):855-9. PubMed ID: 10907978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone-Induced Life-Threatening Refractory Hypotension.
    Doshi D; Jayawardana R
    Am J Case Rep; 2015 Sep; 16():617-20. PubMed ID: 26366832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Hepatotoxicity of Intravenous Amiodarone: Case Report and Review of the Literature.
    Chen CC; Wu CC
    Am J Ther; 2016; 23(1):e260-3. PubMed ID: 25259952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In response to "Anaphylaxis during intravenous administration of amiodarone": is amiodarone the best choice for management of atrial fibrillation?
    Malik I
    Ann Card Anaesth; 2014; 17(1):70-1. PubMed ID: 24401309
    [No Abstract]   [Full Text] [Related]  

  • 36. Amiodarone-induced hypothyroidism and other adverse effects.
    Mosher MC
    Dimens Crit Care Nurs; 2011; 30(2):87-93. PubMed ID: 21307683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Spontaneous remission of an amiodarone-induced pulmonary lesion].
    Müller M; Schima W; Weissel M
    Wien Klin Wochenschr; 1997 Nov; 109(22):887-9. PubMed ID: 9476338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects.
    Cushing DJ; Kowey PR; Cooper WD; Massey BW; Gralinski MR; Lipicky RJ
    Eur J Pharmacol; 2009 Apr; 607(1-3):167-72. PubMed ID: 19232340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study.
    Galve E; Rius T; Ballester R; Artaza MA; Arnau JM; García-Dorado D; Soler-Soler J
    J Am Coll Cardiol; 1996 Apr; 27(5):1079-82. PubMed ID: 8609324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone-induced pulmonary toxicity mimicking acute pulmonary edema.
    Fabiani I; Tacconi D; Grotti S; Brandini R; Salvadori C; Caremani M; Bolognese L
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):361-5. PubMed ID: 19924000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.